Brief: Median Technologies: New iBiopsy Clinical Development Plan For Lung Cancer Screening

Median Technologies SA

16/02/2021 17:08

Feb 16 (Reuters) - Median Technologies SA  ALMDT.PA :
    * IBIOPSY®: MEDIAN TECHNOLOGIES CONTINUES ITS STRONG
POSITIONING
IN EARLY-STAGE DIAGNOSIS WITH A NEW IBIOPSY® CLINICAL
DEVELOPMENT PLAN ON LUNG CANCER SCREENING (LCS)
    * FIRST RESULTS FOR A PROOF OF CONCEPT ON A COHORT OF 1,800
PATIENTS ARE EXPECTED IN H2, 2021

Source text for Eikon:  ID:nBw8QhCyFa 
Further company coverage:  ALMDT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))